Postoperative pulmonary embolism in a young female accompanying with factor V Leiden mutation and hereditary sypherocytosis

Journal of Thrombosis and Thrombolysis

Volumn 17, Issue 3, 2004, Pages 213-217

  Karnak, Demet ^a   Beder, Sumru ^a   Kayacan, Oya ^a   Berk, Özlem ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Anaemia; Foetal loss; FVL mutation; Hereditary spherocytosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; NADROPARIN; WARFARIN;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ANEMIA; ARTICLE; CASE REPORT; CLINICAL PRACTICE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DISEASE SEVERITY; DNA DETERMINATION; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS DEATH; GENE MUTATION; GENERAL PRACTITIONER; GESTATION PERIOD; GESTATIONAL AGE; HEART PALPITATION; HEMATOLOGY; HEPATOSPLENOMEGALY; HEREDITARY SPHEROCYTOSIS; HETEROZYGOSITY; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; LOW BACK PAIN; LUNG EMBOLISM; LUNG SCINTISCANNING; MEDICAL SPECIALIST; MISSED ABORTION; PLEURA EFFUSION; PRIORITY JOURNAL; SCREENING TEST; THORAX DISEASE; THORAX RADIOGRAPHY;

ADULT; CURETTAGE; FACTOR V; FEMALE; FETAL DEATH; HETEROZYGOTE; HUMANS; POINT MUTATION; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PULMONARY EMBOLISM; SPHEROCYTOSIS, HEREDITARY; THROMBOPHILIA;

EID: 4444311957     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000040491.79092.11     Document Type: Article

References (23)

1. Leroyer C, Mercier B, Escoffre M, Ferec C, Mottier D. Factor V Leiden Prevalence in venous Thromboembolism Patients. Chest 1997 111(6):1603-1606.
2. Vandenbroucke JP, Bertina RM, Holmes ZR, et al. Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 1998;79(3):511-516.
3. Heilman Lothar, Schneider D, Tempelhoff GF. Antithrombotic therapy in high-risk pregnancy. Hematol Oncol Clin North Am 2000;14(5):1133-1149.
4. Lawson HW, Atrash HK, Franks AL. Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990;162:986-990.
5. Tanyel FC, Öcal T, Balkanci F, et al. The factor V leiden mutation: A possible contributor to hepatic artery thrombosis encountered after liver transplantation in a child. J Pediatr Surg 2000;35(4):607-609.
6. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in Blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
7. Linker CA. Current Medical Diagnosis and Treatment. In: Tierney LM, Mcpphee SJ, Papadakis MA, eds. Blood. Connecticut: Appleton & Lange, Stamford 1998:479-533.
8. Desmarais S, de Moerloose Ph, Reber G, Minazio Ph, Perrier A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996 347:1374-1375.
9. Faioni EM, Franchi F, Bucciarelli P, et al. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). Blood 1999;94(9):3062-3066.
10. 506-Gln mutation in the gene for factor V (factor V leiden). N Eng J Med 1997;336(6):399-403.
11. Bounameaux H. Factor V Leiden paradox: Risk of deep vein thrombosis but not of pulmonary embolism. Lancet 2000;356(15):182-183.
12. Martinelli I, Catteneo M, Panzeri D, Mannuci PM. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 1997;77:440-443.
13. Ordonez AJ, Carreira JM, Alvarez CR, Rodriguez JM, Alvarez MV, Coto E. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A. Thromb Haemost 2000;83(2):352-354.
14. Turkstra F, Karemaker R, Kuijer PM, Prins ME, Buller HR. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost 1999 81(3):345-348.
15. Baglin TP, Brown K, Williamson D, Baker P, Luddington R. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V leiden mutation in a United Kingdom population. Thromb Haemost 1997;77:1215-1224.
16. Gül A, Özbek U, Öztürk C, Inanc M, Konice M, Özçelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's Disease. Br J Rheum 1996;35:1178-1180.
17. Gürgey A, Rustemov R, Parlak H, Balta G. Prevalence of factor V Leiden and methylenetetrahydrofolate reductase C677T mutation in Azarbaijan. Thromb Haemost 1998;80:520-521.
18. De Stefano V, Mastrangelo S, Paciaroni K, et al. Thrombotic risk during pregnancy and puerperium in women with APC resistance-Affective subcutenous heparin prophylaxis in a pregnant patient. Thromb Haemost 1995;74:793-794.
19. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-905.
20. Mc Coll MD, Ramsay Jei Tait Rc, Walker ID, et al. Risk Factors for Pregnancy Associated venous Thromboembolism. Thromb Haemost 1997 78:1183-1188.
21. Meinardi JR, Middeldorp S, de Kam PJ, et al. Increased risk for foetal loss in carriers of the factor V Leiden mutation. Ann Intern Med 1999 130(9):736-739.
22. Eichinger S, Waltermann A, Philipp K, et al. Haemostatic system activation and thrombin potential in pregnancy. Thromb Haemost 1999 82:1232-1236.
23. Hayag-Barin JE, Smith RE, Tucker FC. Hereditary spherocytosis, and Chronic pulmonary emboli: A case report and review of the literature. Am J Hematol 1998;57:82-84.